Germany's Bayer secures U.S. FDA approval for hemophilia A therapy

March 17 (Reuters) - The U.S. Food and Drug Administration

approved Bayer AG's therapy for the most common form

of hemophilia, about three weeks after the treatment got the

green signal in Europe,...

Read more